Skip to main content
SpringerLink
Log in

The Clinical Impacts of Neutrophil to Lymphocyte Ratio for Esophageal Cancer Patients Who Receive Curative Treatment

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

We investigated the impact of the neutrophil to lymphocyte ratio on esophageal cancer survival and recurrence after curative treatment. This study included 120 patients who underwent curative surgery followed by adjuvant treatment for esophageal cancer between 2008 and 2018. The risk factors for overall survival and recurrence-free survival (RFS) were identified. Neutrophil to lymphocyte ratio of 2.38 was regarded to be the optimal critical point of classification considering the 1-year, 3-year, and 5-year survival rate. The overall survival rates at 3 and 5 years after surgery were 70.5% and 63.0% in the neutrophil to lymphocyte ratio low group, respectively, and 41.0% and 29.7% in neutrophil to lymphocyte ratio high group, which amounted to a statistically significant difference (p=0.001). The recurrence-free survival rates at 3 and 5 years after surgery were 48.6% and 40.7% in the neutrophil to lymphocyte ratio low group, respectively, and 33.6% and 26.9% in neutrophil to lymphocyte ratio high group, which amounted to a statistically significant difference (p=0.046). A multivariate analysis demonstrated that the neutrophil to lymphocyte ratio was a significant independent risk factor for both the overall survival and recurrence-free survival. Neutrophil to lymphocyte ratio was a risk factor for survival in patients who underwent curative treatment for esophageal cancer. It is necessary to develop the effective plan of the perioperative care and the surgical strategy according to the neutrophil to lymphocyte ratio.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492

    Article  PubMed  Google Scholar 

  2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108. https://doi.org/10.3322/caac.21262

    Article  PubMed  Google Scholar 

  3. Muro K, Lordick F, Tsushima T, Pentheroudakis G, Baba E, Lu Z, Cho BC, Nor IM, Ng M, Chen LT, Kato K, Li J, Ryu MH, Zamaniah WIW, Yong WP, Yeh KH, Nakajima TE, Shitara K, Kawakami H, Narita Y, Yoshino T, Van Cutsem E, Martinelli E, Smyth EC, Arnold D, Minami H, Tabernero J, Douillard JY (2019) Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS. Ann Oncol 30:34–43. https://doi.org/10.1093/annonc/mdy498

    Article  CAS  PubMed  Google Scholar 

  4. Lordick F, Mariette C, Haustermans K, Obermannová R, Arnold D, ESMO guidelines Committee. Oesophageal cancer (2016) ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 27:v50–v57

    Article  CAS  PubMed  Google Scholar 

  5. DeNardo DG, Johansson M, Coussens LM (2008) Immune cells as mediators of solid tumor metastasis. Cancer Metastasis Rev 27:11–18. https://doi.org/10.1007/s10555-007-9100-0

    Article  CAS  PubMed  Google Scholar 

  6. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet. 357:539–534. https://doi.org/10.1016/S0140-6736(00)04046-0

    Article  CAS  PubMed  Google Scholar 

  7. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883–899. https://doi.org/10.1016/j.cell.2010.01.025

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Roxburgh CS, McMillan DC (2010) Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 6:149–163. https://doi.org/10.2217/fon.09.136

    Article  CAS  PubMed  Google Scholar 

  9. Hara K, Aoyama T, Yamada T, Nakazono M, Nagasawa S, Shimoda Y, Kumazu Y, Numata M, Hayashi T, Tamagawa H, Shiozawa M, Morinaga S, Yukawa N, Rino Y, Masuda M, Ogata T, Oshima T (2020) The prognostic value of the perioperative systemic inflammation score for patients with advanced gastric cancer. Anticancer Res:1503–1512. https://doi.org/10.21873/anticanres.14095

  10. Kano K, Aoyama T, Maezawa Y, Hayashi T, Yamada T, Tamagawa H, Sato T, Cho H, Yoshikawa T, Rino Y, Masuda M, Oshima T, Ogata T (2019) Postoperative level of C-reactive protein is a prognosticator after esophageal cancer surgery with perioperative steroid therapy and enhanced recovery after surgery care. In Vivo 33:587–594. https://doi.org/10.21873/invivo.11515

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Templeton AJ, Ace O, McNamara MG, Al-Mubarak M, Vera-Badillo FE, Hermanns T, Seruga B, Ocaña A, Tannock IF, Amir E (2014) Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev 23:1204–1212. https://doi.org/10.1158/1055-9965.EPI-14-0146

    Article  CAS  Google Scholar 

  12. Stotz M, Gerger A, Eisner F, Szkandera J, Loibner H, Ress AL, Kornprat P, AlZoughbi W, Seggewies FS, Lackner C, Stojakovic T, Samonigg H, Hoefler G, Pichler M (2013) Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer 109:416–421. https://doi.org/10.1038/bjc.2013.332

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Kao SC, Pavlakis N, Harvie R, Vardy JL, Boyer MJ, van Zandwijk N, Clarke SJ (2010) High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res:5805–5813. https://doi.org/10.1158/1078-0432.CCR-10-2245

  14. Chua W, Charles KA, Baracos VE, Clarke SJ (2011) Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer 104:1288–1295. https://doi.org/10.1038/bjc.2011.100

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Absenger G, Szkandera J, Pichler M, Stotz M, Arminger F, Weissmueller M, Schaberl-Moser R, Samonigg H, Stojakovic T, Gerger A (2013) A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients. Br J Cancer 109:395–400. https://doi.org/10.1038/bjc.2013.346

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Xie X, Luo KJ, Hu Y, Wang JY, Chen J (2016) Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer. Dis Esophagus 29:79–85. https://doi.org/10.1111/dote.12296

    Article  CAS  PubMed  Google Scholar 

  17. Xu AM, Huang L, Zhu L, Wei ZJ (2014) Significance of peripheral neutrophil-lymphocyte ratio among gastric cancer patients and construction of a treatment-predictive model: a study based on 1131 cases. Am J Cancer Res 4:189–195

    PubMed  PubMed Central  Google Scholar 

  18. Kano S, Homma A, Hatakeyama H, Mizumachi T, Sakashita T, Kakizaki T, Fukuda S (2017) Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer. Head Neck:247–253. https://doi.org/10.1002/hed.24576

  19. Koh CH, Bhoo-Pathy N, Ng KL, Jabir RS, Tan GH, See MH, Jamaris S, Taib NA (2015) Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer. Br J Cancer 113:150–158. https://doi.org/10.1038/bjc.2015.183

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Sharaiha RZ, Halazun KJ, Mirza F, Port JL, Lee PC, Neugut AI, Altorki NK, Abrams JA (2011) Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol 18:3362–3369. https://doi.org/10.1245/s10434-011-1754-8

    Article  PubMed  PubMed Central  Google Scholar 

  21. Kosumi K, Baba Y, Ishimoto T, Harada K, Nakamura K, Ohuchi M, Kiyozumi Y, Izumi D, Tokunaga R, Taki K, Higashi T, Miyata T, Kurashige J, Hiyoshi Y, Iwagami S, Sakamoto Y, Miyamoto Y, Yoshida N, Watanabe M, Baba H (2016) Neutrophil/lymphocyte ratio predicts the prognosis in esophageal squamous cell carcinoma patients. Surg Today 46:405–413. https://doi.org/10.1007/s00595-015-1197-0

    Article  CAS  PubMed  Google Scholar 

  22. Pirozzolo G, Gisbertz SS, Castoro C, van Berge Henegouwen MI, Scarpa M (2019) Neutrophil-to-lymphocyte ratio as prognostic marker in esophageal cancer: a systematic review and meta-analysis. J Thorac Dis 11:3136–3145. https://doi.org/10.21037/jtd.2019.07.30

    Article  PubMed  PubMed Central  Google Scholar 

  23. Gregory AD, Houghton AM (2011) Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res 71:2411–2416. https://doi.org/10.1158/0008-5472.CAN-10-2583

    Article  CAS  PubMed  Google Scholar 

  24. Sato H, Tsubosa Y, Kawano T (2012) Correlation between the pretherapeutic neutrophil to lymphocyte ratio and the pathologic response to neoadjuvant chemotherapy in patients with advanced esophageal cancer. World J Surg 36:617–622. https://doi.org/10.1007/s00268-011-1411-1

    Article  PubMed  Google Scholar 

  25. Vulliamy P, McCluney S, Mukherjee S, Ashby L, Amalesh T (2016) Postoperative elevation of the neutrophil: lymphocyte ratio predicts complications following esophageal resection. World J Surg 40:1397–1403. https://doi.org/10.1007/s00268-016-3427-z

    Article  PubMed  Google Scholar 

  26. Hirahara N, Matsubara T, Hayashi H, Takai K, Fujii Y, Tajima Y (2015) Impact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancer. Eur J Surg Oncol 4:1308–1315. https://doi.org/10.1016/j.ejso.2015.07.008

    Article  Google Scholar 

  27. Nakamura K, Yoshida N, Baba Y, Kosumi K, Uchihara T, Kiyozumi Y, Ohuchi M, Ishimoto T, Iwatsuki M, Sakamoto Y, Watanabe M, Baba H (2017) Elevated preoperative neutrophil-to-lymphocytes ratio predicts poor prognosis after esophagectomy in T1 esophageal cancer. Int J Clin Oncol 22:469–475. https://doi.org/10.1007/s10147-017-1090-5

    Article  PubMed  Google Scholar 

  28. Shao Y, Ning Z, Chen J, Geng Y, Gu W, Huang J, Pei H, Shen Y, Jiang J (2015) Prognostic nomogram integrated systemic inflammation score for patients with esophageal squamous cell carcinoma undergoing radical esophagectomy. Sci Rep 5:18811. https://doi.org/10.1038/srep18811

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Yuan D, Zhu K, Li K, Yan R, Jia Y, Dang C (2014) The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction. J Surg Oncol 110:333–340. https://doi.org/10.1002/jso.23651

    Article  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. Toru Aoyama and Kenki Segami contributed equally to this work.

Authors and Affiliations

  1. Department of Surgery, Yokohama City University, 3-9 Fukuura Kanazawa-ku, Yokohama, Japan

    Toru Aoyama, Kenki Segami, Shinnosuke Nagasawa, Hiroshi Tamagawa, Ayako Tamagawa, Yukio Maezawa, Kazuki Kano, Masato Nakazono, Takashi Oshima, Norio Yukawa, Munetaka Masuda & Yasushi Rino

Authors
  1. Toru Aoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenki Segami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shinnosuke Nagasawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroshi Tamagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ayako Tamagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yukio Maezawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kazuki Kano
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Masato Nakazono
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Takashi Oshima
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Norio Yukawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Munetaka Masuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yasushi Rino
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Toru Aoyama.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aoyama, T., Segami, K., Nagasawa, S. et al. The Clinical Impacts of Neutrophil to Lymphocyte Ratio for Esophageal Cancer Patients Who Receive Curative Treatment. Indian J Surg 84, 86–93 (2022). https://doi.org/10.1007/s12262-021-02830-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-021-02830-1

Keywords

Search

Navigation